US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
オーストラリア
ASX
Aroa Biosurgery Limited (ARX) 銘柄情報

Aroa Biosurgery Limited (ARX)

0.65

0.035

( 5.69% )

更新日時： 14:43:29

Aroa Biosurgery Limited (ARX) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.65

( 5.69% )

買値

0.65

売値

0.655

出来高

168,770

0.61 日の範囲 0.66

0.46 52 週間の範囲 0.80

時価総額

前日終値

0.615

始値

0.61

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 177,151

発行済株式数

345,902,653

配当利回り

PER

59.89

1 株当たり利益 (EPS)

0.01

歳入

103.85M

純利益

4.68M

Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute... Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; Myriad Morcells Fine that delivers a bolus of biologically important ECM proteins to help kick start and sustain healing; and Symphony, a combination cellular and tissue product, indicated for the regeneration of functional tissue in complex wounds. The company also develops products for abdominal wall reconstruction, hernia repair, and breast reconstruction in North America and Europe. Aroa Biosurgery Limited was incorporated in 2007 and is headquartered in Auckland, New Zealand. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

aroa.com

本社

Auckland, New Zealand

設立

2026

Aroa Biosurgery Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker ARX. The last closing price for Aroa Biosurgery was AUD0.62. Over the last year, Aroa Biosurgery shares have traded in a share price range of AUD 0.46 to AUD 0.80.

Aroa Biosurgery currently has 345,902,653 shares in issue. The market capitalisation of Aroa Biosurgery is AUD224.84 million. Aroa Biosurgery has a price to earnings ratio (PE ratio) of 59.89.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.025	-3.7037037037	0.675	0.675	0.61	172654	0.64363454	DE
4	0.02	3.1746031746	0.63	0.7	0.59	219964	0.63953371	DE
12	0.07	12.0689655172	0.58	0.7	0.495	194951	0.6031926	DE
26	-0.0325	-4.7619047619	0.6825	0.775	0.495	160162	0.63890014	DE
52	0.13	25	0.52	0.8	0.46	207743	0.65380786	DE
156	-0.22	-25.2873563218	0.87	9.4	0.35	309865	0.61735943	DE
260	-0.415	-38.9671361502	1.065	9.4	0.35	298703	0.75846016	DE

ARX - Frequently Asked Questions (FAQ)

What is the current Aroa Biosurgery Limited share price?

The current share price of Aroa Biosurgery Limited is AUD 0.65

How many Aroa Biosurgery Limited shares are in issue?

Aroa Biosurgery Limited has 345,902,653 shares in issue

What is the market cap of Aroa Biosurgery Limited?

The market capitalisation of Aroa Biosurgery Limited is AUD 224.84M

What is the 1 year trading range for Aroa Biosurgery Limited share price?

Aroa Biosurgery Limited has traded in the range of AUD 0.46 to AUD 0.80 during the past year

What is the PE ratio of Aroa Biosurgery Limited?

The price to earnings ratio of Aroa Biosurgery Limited is 59.89

What is the cash to sales ratio of Aroa Biosurgery Limited?

The cash to sales ratio of Aroa Biosurgery Limited is 2.57

What is the registered address of Aroa Biosurgery Limited?

The registered address for Aroa Biosurgery Limited is 64 Richard Pearse Drive, Auckland, 2022

What is the Aroa Biosurgery Limited website address?

The website address for Aroa Biosurgery Limited is aroa.com

Which industry sector does Aroa Biosurgery Limited operate in?

Aroa Biosurgery Limited operates in the Medical Equipment & Supplies sector

space~farm

space~farm 15分前

I can only imagine the deficiencies in their submission. This will be caught up in a never ending RFI.

jxyzobrien

jxyzobrien 18分前

criminals run the country
so nothing will be done
lots of boot lickers

jxyzobrien

jxyzobrien 19分前

bull market till qe dies
new fed chair will have some say next week
till change is clear its qe as usual.

rx7171

rx7171 20分前

Negativity is primarily the funk we feel that we see extremely positive data that needs a longer and larger trial to get approval, delaying the approval for a minimum of three years.

Whether Anavex will even exist by then or be bought out is the unknown.

An investor’s b

JohnnyRotton

JohnnyRotton 33分前

Most are stuck, this state allows unlimited shares if I remember right. They can dilute forever. Only a few will ever get out without a rs or buy back. They are making enough cash to do either if they choose. The stock cant achieve true value via rs because market cap is 1/10th actual value now. Tou

skitahoe

skitahoe 33分前

During the past 5 or so years our market cap has shrunk from nearly $1 billion to the $307 million it is today. Dilution is less than doubled, yet the market cap is under about a third of what it was. The point is, LP has added much extra values, FlaskWorks, Advent, Roswell, etc. to what the compa

Dorick

Dorick 33分前

Physics Inspector General files NEW Complaint to SEC Against Dennis Danzik, FlooidCX, Quantum Energy Inc, and Inductance Energy

See: https://physicsinspector.wordpress.com/2026/06/11/new-complaint-against-dennis-danzik-flooidcx-quantum-energy-inc-and-inductance-energy/

Dorick

Dorick 38分前

Physics Inspector General files NEW Complaint to SEC Against Dennis Danzik, FlooidCX, Quantum Energy Inc, and Inductance Energy

See: https://physicsinspector.wordpress.com/2026/06/11/new-complaint-against-dennis-danzik-flooidcx-quantum-energy-inc-and-inductance-energy/

Nemesis18

Nemesis18 38分前

It should be abundantly clear by now, that as I stated, immediately after the application was filed with the Regulator, that it was pulled out of line by external Agencies, for a special audit.
And that since then, it has been under a state of, almost continuous RFI, whilst the investigation

Genz2

https://www.techadvisor.com/article/3144140/trump-mobile-t1-phone-worst-fears-realised.html

Hey Methinks, you know what would give these Trump phones an edge….?? Yes TRUST @ THE EDGE!!!! WHY WAVE OF COURSE!!!!! Trump could have the PREMIERE SECURITY PHONE WITH WAVE!!!! He could se

surfer44

surfer44 42分前

10th Capital Link Maritime Leaders Summit – Greece | Tanker Markets in Motion

https://youtu.be/cQmTuuAZef8

wildwertski

wildwertski 43分前

Not to be a negative Nelly, but this is what happens when you have an app in beta for a whole year and wait for 3 weeks before the big day to start making serious updates. I sure hope someone can pull a rabbit out from behind that proverbial curtain soon. Getting "blown away" isn't working for us.

Stockman1010101

Stockman1010101 45分前

All the IPO underwriters are making a fortune running these MEGA IPOs. I suspect all the big name underwriters will be stinky rich when Fannie & Freddie have their long awaited IPO.
HOLD THEM.SHARES THEY WILL BE WORTH NORTH OF $100/SHARE SOON.
GLTA

rjs1

Rainmaker 2026 Valuation Model

Three Layer Architecture:
• Asset Light Corporate Layer (RAKR HQ – Canada)
• Operating Layer (Miranda Water Technologies)
• Market Nodes (U.S., Canada, Mexico)
Each layer has its own valuation logic, revenue cadence, and ri

JusticeWillWin

JusticeWillWin 50分前

Again ~3.5M at the close...

Sleepy$$$

Sleepy$$$ 1時間前

Outstanding Shares642,268,09705/29/2026Restricted625,012,64605/29/2026

Per otcmarkets.... float is tiny

Duke Knockem

Duke Knockem 1時間前

I asked Belisarian holdings if they would take over Gs tickers, they didn't respond, but they 'liked' my post on Twitter. In 4 years it was only the second time they liked one of my post....🤷....to take with a grain of salt

nowwhat2

nowwhat2 1時間前

STOP

https://www.youtube.com/watch?v=JNhayv6hBeo
https://investorshub.advfn.com/uimage/uploads/2026/6/12/netmygold_june_11_3m_daily_w_asian_guy.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/udfnigold_june_11_3y_w_asian_guy.jpg

https:/

nowwhat2

nowwhat2 1時間前

STOP

https://www.youtube.com/watch?v=JNhayv6hBeo
https://investorshub.advfn.com/uimage/uploads/2026/6/12/netmygold_june_11_3m_daily_w_asian_guy.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/udfnigold_june_11_3y_w_asian_guy.jpg

https:/

axelvento

axelvento 1時間前

Ovarian cancer CAR-T therapy, lira-cel, presentation to highlight positive survival observations from ongoing Phase 1 clinical trial

Breast cancer vaccine presentation to include final Phase 1 data showing all major primary endpoints were met and protocol-defined immune responses in 7

JohnnyRotton

JohnnyRotton 1時間前

Wasn't to get sellers cause no one bought my sell order, cant get out now. Stuck. Just a small order.

jimr1717

jimr1717 1時間前

I seriously doubt Nelson or Hawkins care who their marks are that they dump their shares on

ElectricDwarf15

ElectricDwarf15 1時間前

Stuck short INHD after the T12 halt and looking to connect with anyone holding long shares who wants to exit.

I'm with Cobra DM me if interested.

knrorrel

knrorrel 1時間前

$PAVD - It kicks off today. You might think—after the stock was bought up at a really nice, low price yesterday—that we’re going to skyrocket today, and all the people who didn't have the guts to buy yesterday and have been waiting on the sidelines will jump in; the stock could become a multi-dolla

ap17

ap17 1時間前

Word on the street, the village Idiot, aka sims is going to change the traffic pattern. LMFAO
Don't forget! This about YOU! OUCH!!!
Might want to change that traffic pattern....so you can sit! LMFAO!!

https://www.instagram.com/p/DSS1QQ4EZk9/

Aroa Biosurgery

Bitwise 10 Crypto (QX)

Zero Cpn Nts 20/06/27

Lanesborough Real Estate...

TCW Transform 500 ETF

Lehman Brothers Financial (EM)

Justiss Oil (EM)

Dream Homes and Developm... (EM)

Egdon Resources

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。